ERJ Open Research

Article	Citations
Dual CFTR modulator therapy efficacy in the real world: lessons for the future	279
Long-term incident severe outcomes in a prospective cohort of non-obese obstructive sleep apnoea patients free of comorbidities at inclusion	68
Williams–Campbell syndrome case series and discordant twins	46
Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis	45
Extracellular iron and the lung microbiome in smoking and COPD	42
ROHHAD syndrome in an adult: presence of ZSCAN1 antibodies	39
Proteins associated with preserved ratio impaired spirometry	35
Targeted DNase treatment of obstructive lung disease: a pilot randomised controlled trial	35
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly	35
Diagnosis of pulmonary embolism in patients with haemoptysis: the POPEIHE study	33
Prevalence and consequences of patient–ventilator interactions in a cohort of home-ventilated restrictive and neuromuscular patients: a multicentre study	32
Prednisolone for COPD exacerbations: time for a rethink	32
Shape of the association between endotoxin in school dust and children's lung function	31
Antitrypsin deficiency: still more to learn about the lung after 60 years	31
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw	31
Period and cohort effects: consequences on spirometric lung function in Norway during the 20th century	31
Clinical impact of routine sleep assessment by peripheral arterial tonometry in patients with COPD	30
Rapid molecular detection of respiratory pathogens in patients with bronchiectasis	29
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory	28
Spirometry at different Latin American altitudes: a Global Lung Function Initiative project	28
A survey of UK respiratory specialists’ opinion on the management of chronic cough	28
Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance	27
Anodal transcranial direct current stimulation over the right primary somatosensory cortex increases cough reflex sensitivity: a pilot randomised controlled crossover trial	26
Phase III AIRTIVITY™ study design – verducatib (BI 1291583) in people with bronchiectasis	26
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study	26

Global survey of physician testing practices for nontuberculous mycobacteria	26
Dendritic cells in the lung cavities of extensively drug-resistant tuberculosis patients exhibit altered frequency and phenotype	25
The role of clamping before removal of a chest tube in post-surgical and pneumothorax patients using digital drainage systems: a noninferiority randomised trial	25
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction	25
Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality	25
The NEuroCOUGH Chronic Cough Registry: a protocol for a pan-European observational study	25
Triple therapy in COPD: understanding the data	25
Validation of the General Practice Physical Activity Questionnaire after severe COVID-19	24
Managing breathlessness for people with advanced respiratory disease	24
Supplements and medications for respiratory resilience against air pollution	24
The long-term effects of insulin use in incident cystic fibrosis-related diabetes: a target trial emulated using longitudinal national registry data	24
Diagnostic delay in bronchiectasis: an Italian perspective	23
Artificial intelligence augmentation raises questions about the future of bronchoscopy	23
Serotype distribution and coverage by pneumococcal vaccines in hospitalised adults with pneumococcal pneumonia in Germany	23
Prevalence and types of treatable traits in bronchiectasis: a multicentre, cross-sectional study	23
A comprehensive evaluation of murine and humanex vivocultured alveolar macrophages	23
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea	22
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry	22
Shankh blowing in obstructive sleep apnoea: something special or a routine respiratory exercise?	22
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey	22
“Dysregulation of lipid mediators in patients with frequent exacerbations of COPD” Marie Fisk, Esteban A. Gomez, Yuan Sun, Monika Mickute, Carmel McEniery, John R. Cockcroft, Charlotte Bolton, Jonatha	22
Slow deep breathing reduces muscle sympathetic nerve activity and improves breathing efficiency in pulmonary hypertension	22
Utility of rehabilitation prior to bronchoscopic lung volume reduction:post hocanalysis of the VENT trial	22
Predicting clinical exacerbations using respiratory oscillometry during home telemonitoring of patients taking medium-/high-dose asthma treatment	22
Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia	21
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation	21
Improvements in small airway dysfunction and respiratory symptoms following Tezepelumab for severe asthma	21
Achieving adherence to positive airway pressure in commercial drivers using an employer-mandated remote management programme	21
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort	21
Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score	21
High-frequency percussive ventilation in acute respiratory failure	21
Epidemiology, risk factors, and clinical outcome of community-acquired pneumonia in severely immunosuppressed patients: a comprehensive analysis from the multinational prospective	21
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease	20
Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial	20
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases	20
The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma	20
Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis	20
Safety and feasibility of ultrathin probe transbronchial lung cryobiopsy without balloon blockerviarobotic bronchoscopy in the evaluation of peripheral lung lesions: a retrospective pilot study	20
Effects of seasonality and treatment on COPD clinical outcomes: IMPACTpost hocanalysis	20
Cell-free Tumor DNA in Bronchoalveolar Lavage- a proof of concept study	19
A robust web-based tool to predict viral shedding in patients with Omicron SARS-CoV-2 variants	19
Optimal follow-up duration for nonspecific pleuritis: how long is long enough?	19
Biomarkers of chronic airflow limitation and COPD identified by mass spectrometry	19
Sarcopenia does not affect dyspnoea in patients with interstitial lung disease	19
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis	19
Hospitalisation outcomes in pneumococcal-vaccinatedversus-unvaccinated patients with exacerbation of COPD: results from the HOPE COPD Study	19
Associations of physical activity and quality of life in parapneumonic effusion patients	19
Interstitial lung abnormalities: do symptoms matter?	19
Immunological biomarkers predict pulmonary and nodal, but not cardiac PET-assessed sarcoidosis activity	19
Clinical assessment of balance and functional impairments in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis	18

Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis	18
The construct validity of real-world digital mobility outcomes in people with COPD	18
Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema	18
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database	18
Systemic inflammation and oxidative stress in bronchiectasis-associated sarcopenia	18
Socioeconomic inequalities in severe childhood asthma: results of a nationwide cohort	18
Add-on mepolizumab in patients with severe asthma on medium-dose inhaled corticosteroids	18
α 1 -Antitrypsin deficiency and increased risk of atrial fibrillation in two large population-based cohorts	18
Home sleep studies in children with neurodisabilities: success rates and parental perception	18
Clinical impact and healthcare resource utilisation in patients with unexplained or refractory chronic cough: a French national population study	18
Race-neutral spirometry reclassification in self-identified black and white patients	18
Right ventricular–pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension	18
Time to negative conversion and cardiopulmonary performance in athletes with COVID-19	17
Developing a self-management package for pulmonary fibrosis: an international Delphi study	17
Treatable traits and hospitalisations in asthma: the comorbidity conundrum	17
Key priorities to prevent avoidable asthma hospitalisations: insights from end-users	17
Patient education and self-management in interstitial lung disease: why and what, now how?	17
Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived	17
Navigating family dynamics and ethical considerations in genetic diagnosis of pulmonary arterial hypertension: insights from in-depth semi-structured interviews	17
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea	17
A worldwide look into long COVID-19 management: an END-COVID survey	17
To burn or not to burn: similar effects of different types of prenatal tobacco exposure on infant lung function	17
Single-Cell RNA-seq Reveals Aberrant Airway Epithelial-Immune Cell Crosstalk In Pulmonary Fibrosis	16
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study	16
Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation	16
Frailty and social, clinical and computed tomography imaging factors in COPD: a multicentre study	16
Chaotic breathing in post-COVID-19 breathlessness: a key feature of dysfunctional breathing can be characterised objectively by approximate entropy	16
Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial	16
Persistent tachypnoea of infancy and neuroendocrine cell hyperplasia of infancy: from systematic review to future directions	16
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis	16
“Pre-diagnosed sleep apnoea is linked to severe courses in community-acquired pneumonia” Thomas Bitter, Matthias W. Pletz, Martin Witzenrath, Jan Rupp and Gernot Rohde for the CAPNETZ-Studygroup.	16
How to distinguish PPI-refractory from PPI-responsive patients in gastro-oesophageal reflux-induced chronic cough: post-reflux swallow induced peristaltic wave index and mean nocturnal baseline impeda	16
Clinical validation of respiratory outcomes for a patch-based polysomnography system	16
Deep-learning networks accurately detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis	15
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics	15
Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structures	15
Oxygen saturation targets for children with respiratory distress: a systematic review	15
Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study	15
e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseases	15
Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID	15
Incidence and predictors of self-reported pulmonary exacerbations in primary ciliary dyskinesia: an international prospective cohort study	15
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis	15
Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: a nationwide cohort study	15
Should all patients with COPD be treated with inhaled triple therapy?	15
Modifiable lifestyle risk factors for sarcoidosis: a nested case–control study	15
Menthol inhalation relieves dyspnoea through the brain	15
“Breathlessness stops me doing everything”: exploring the impact of chronic breathlessness due to advanced respiratory disease and exacerbating factors – a qualitative study	14
Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients	14
Reply: Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma	14
Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19	14
Effects of exercise and a lifestyle app on sleep disordered breathing, physical health and quality of life	14
Rapid real-world implementation of pulmonary telerehabilitation: good fortune or COVID-19 luck?	14
Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype	14
It is time to end our love affair with short-acting β2-agonists in asthma? Yes	14
The feasibility of implementing clinical decision support system software in the outpatient assessment of breathlessness: Cardio-LungHealth and Everton in the Community	14
Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis	14
Dupilumab-associated hypereosinophilia in severe asthma	14
Reply: Respiratory burden in post-acute COVID-19 sequelae: a longitudinal study	14
Infant lung function: criteria for selecting tidal flow–volume loops	14
The effect of electrical stimulation of the upper airway dilator muscles on blood pressure in healthy volunteers and patients with obstructive sleep apnoea: a systematic review and meta-analysis	14
Shorter walk test durations to detect ambulatory oxygen desaturation in interstitial lung disease: an observational cohort study	14
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial	14
Upper-lobe CT imaging features improve prediction of lung function decline in COPD	14
Intimal granulomatous angiitis in sarcoid pulmonary vasculitis: worth remembering	14
Possible overdiagnosis of early-stage lung adenocarcinoma among never-smokers in Taiwan	14
Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease	14
Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluation	14
Still no room to breathe: insights on supine lung mechanics from oscillometry in COPD	14
ERS Congress 2024: highlights from the Basic and Translational Sciences Assembly	13
Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin	13
A focus group study about healthcare professionals’ perspectives on patient education in pulmonary rehabilitation	13
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma	13
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population	13
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension	13
Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2	13
Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients withEGFR-mutated non-small cell lung cancer treated with afatinib	13
“Influence of physical activity on the prognosis of COPD patients: the HADO.2 score – health, activity, dyspnoea and obstruction”. Cristóbal Esteban, Nere Larrea, Amaia Aramburu, Javier Moraza, Leyre	13
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts	13
Association of German Bronchiectasis Registry participation with disease course	13
Redefining chronic cough as a disease: why patient registries matter	13

Acknowledging the syndemic: a real-life cohort study of major adverse cardiovascular events in COPD	13
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study	13
Airway Smooth Muscle in Asthma: Insights from a Transcriptomic Meta-analysis	13
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis	13
Cardiac dysfunction during exercise in young adults with bronchopulmonary dysplasia	13
Comparative Analysis of FEV 1 Expressions: Association with All-Cause Mortality	12
Response to endobronchial valve treatment: it's all about the target lobe	12
ERS Congress 2024: highlights from the Clinical Techniques, Imaging and Endoscopy Assembly	12
ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly	12
Beyond spirometry: understanding COPD origins to support a new diagnostic approach	12
Ever-smokers in Norway and lung cancer: median time from self-reported smoking debut to lung cancer diagnosis in eleven prospective Norwegian population studies (CONOR)	12
Acute and 14-day effects of tiotropium/olodaterol on cardiopulmonary function in COPD	12
Physical capacity and inactivity in obstructive airway diseases: a “can do, do do” analysis	12
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort	12
Reduced cough severity and improved confidence in self-management following completion of a Virtual Physiotherapy Group Intervention for Chronic Cough: ViP-Cough	12
Normal values of respiratory oscillometry in South African children and adolescents	12
Home is where spirometry should be: enhancing care for individuals with pulmonary fibrosis	12
“A pulmonary rehabilitation shared decision-making intervention for patients living with COPD: PReSent: protocol for a feasibility study”. Amy C. Barradell, Linzy Houchen-Wolloff, Noelle Robertson, Hi	12
Systemic pro-inflammatory response following bronchoscopic lung volume reduction using endobronchial valves	12
Upper-limb intervalversusconstant-load exercise in patients with COPD: a physiological crossover study	12
Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study	12
Artificial intelligence and radiomics in drug-induced interstitial lung disease	12
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension	12
Feasibility of using continuous positive airway pressureviathe LeVe CPAP System among children with acute hypoxaemic respiratory failure at Mengo Hospital, Kampala, Uganda: a mixed-methods stud	12
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) – a cohort study	12
Locus of control and breathlessness: a cross-sectional analysis of 28 730 people	12
Spirometry interpretation in primary care: is there a role for artificial intelligence?	12
The role of the ADRB2 Thr164Ile variant in lung function determination, plasma proteome variability and other phenotypes in UK Biobank	12
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases	12
Diffuse panniculitis in a teenage male with ZZ α1-antitrypsin deficiency	12
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma	12
Compartment-specific protein interactions in beryllium lung disease	12
Insights from the INSIGHTS-ILD Registry: real-world heterogeneity in treatment patterns for patients with fibrotic interstitial lung disease	12
Adverse perception of cough in patients with severe asthma: a discrete choice experiment	12
Methicillin-resistant Staphylococcus aureus and pulmonary outcome in people with cystic fibrosis: a European Cystic Fibrosis Patient Registry data analysis	12
Obstructive sleep apnoea-related respiratory events and desaturation severity are associated with the cardiac response	12
Risk factors and interventions for developing recurrent pneumonia in older adults	11
The Palestinian primary ciliary dyskinesia population: first results of the diagnostic and genetic spectrum	11
Exercise responses and mental health symptoms in COVID-19 survivors with dyspnoea	11
Diagnostic, prognostic, and therapeutic challenges in patients with Hypersensitivity Pneumonitis	11
Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension	11
Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction	11
Persistence of lung hyperinflation and small airway dysfunction in school-aged children with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor: results from the real-world MODUL-CF study	11
Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial	11
The effect of exacerbations on lung density in α1-antitrypsin deficiency	11
An exploration of clinically meaningful definitions of cough bouts	11
Lung disease in never-smokers with severe α 1 -antitrypsin deficiency: the EARCO Registry	11
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD	11
Laboratory and free-living gait performance in adults with COPD and healthy controls	11
Predictors of invasive mechanical ventilation use in patients with acute decompensated pulmonary hypertension admitted to the intensive care unit	11
Inhaler Mastery and Retention after Stepwise Training in Cognitively Impaired Older COPD	11
Creatine supplementation and respiratory muscle function in health and disease: translational insights from human to mouse	11
Characteristics and management of asthma from the China Asthma Data Registry Project	11
Activation of STAT3 in the COPD airway epithelium	11
Living with chronic cough: experiences, burden and management in interstitial lung disease – a mixed methods study	11
Is it time for a simplified method to evaluate airway eosinophilia?	11
The association of weather conditions with day-to-day variability in physical activity in patients with COPD	11
Artificial intelligence improves bronchoscopy performance: a randomised crossover trial	11
Clinical utility of sputum cytology in severe asthma: insights from a specialist centre	11
Longitudinal change in ultrasound-derived rectus femoris cross-sectional area in COPD	11
Early benefit of mepolizumab on small airways in severe asthma: insights from the IMPOSE study	11
BOS-318 treatment enhances elexacaftor–tezacaftor–ivacaftor-mediated improvements in airway hydration and mucociliary transport	10
Airflow obstruction among young adults in Europe: a Chronic Airway Diseases Early Stratification (CADSET) collaboration with 48 612 individuals across eight population-based cohorts	10
Chronic noninvasive ventilation in COPD: towards the identification of a responder phenotype	10
Efficacy of morphine on cough in patients with repeat expansions of RFC1 and refractory chronic cough	10
Efficacy of interventions to alter measures of fat-free mass in people with COPD: a systematic review and meta-analysis	10
Diagnostic Performance of Thoracic Ultrasound and Shear Wave Elastography in Detecting Malignant Pleural Effusion: A Comprehensive Systematic Review and Meta-analysis of Different Ultrasonographic Sig	10
Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years	10
OSA symptom subtypes and hypoxic burden independently predict distinct cardiovascular outcomes	10
Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis	10
Does COVID-19 vaccination increase the risk of interstitial lung disease at a population level?	10
The effects of dual IQOS and cigarette smoke exposure on airway epithelial cells: implications for lung health and respiratory disease pathogenesis	10
Conservation of gene expression patterns between the amniotic and nasal epithelium at birth	10
Delayed airway epithelial repair is correlated with airway obstruction in young adults born very preterm	10
Utility of diaphragm dome height as a marker of operational lung volume changes, disease burden and exacerbations in patients with mild-to-moderate COPD: an observational study within the CanCOLD coho	10
Post-viral lung diseases: the microbiota as a key player	10
Mirror, mirror on the wall: is CompEx the fairest endpoint of all?	10
Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion	10
Voice as biomarker for early exacerbation detection in asthma and COPD: the TACTICAS study	10
Circadian variability in breath volatiles is affected by the timing of inhaled corticosteroids in asthma	10
Peeping at COPD through the keyhole: time to broaden the view to the complexity of the disease by the heterogeneity of symptoms	10
NKX2.1mutation revealed by a lymphoid interstitial pneumonia in an adult with rheumatoid arthritis	10
Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review	10
Effects of acetazolamide on sleep disordered breathing in pulmonary vascular disease: a randomised controlled trial	10
Multidisciplinary rehabilitation in intensive care for COVID-19: randomised controlled trial	10
Identification of two distinct molecular endotypes in cough-variant asthma based on sputum transcriptomics and clinical pathophysiological features	10
Characteristics of severe disease in GL-ILD: a retrospective cohort study	10
Validation and cross-cultural insights of the French translation of the Severe Asthma Questionnaire	10
ERS International Congress 2023: highlights from the Respiratory Intensive Care Assembly	10
Telemonitoring for the follow-up of home noninvasive ventilation: a promising future with ongoing challenges	10
Factors most strongly associated with breathlessness in a population aged 50–64 years	10
ERS Congress 2024: highlights from the Respiratory Intensive Care Assembly	10
A cystic and bullous lung disease associated with a PIK3CA-related overgrowth syndrome	10
Performance of two portable exhaled nitric oxide fraction devices compared to a “gold standard” chemiluminescence device	10
Exploring lung cavity access to endobronchial valve in chronic pulmonary aspergillosis and nontuberculosis mycobacterial diseases, a radiological feasibility study	10